The Pathogenetic Role Of Platelet Nitric Oxide In Children With Nephropathy
Abstract
In order to investigate the role of NO in pathogenesis of nephropathy in children we examined 29 patients (from 4 to 14 year old) with different kidney diseases and normal renal function. In all of them NO platelet synthesis was measured by spectrofotometric determination of its stable metabolites (NO2-+NO3-). The investigation confirms the important role of NO in pathogenesis of kidney dieases. The increased NO platelet synthesis in children with nephropathy is associated with high activity of inflammation in renal tissue. The difference between patients with pyelonephritis and glomerulonephritis may be a reflection of different inflammatory mechanisms of these diseases.
About the Authors
S. S. Paunova
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
A. G. Kycherenko
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
Ch. M. Marcov
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
L. A. Revenkova
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
N. L. Goltsova
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
E. A. Temerina
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
O. V. Anokhina
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
V. I. Komar
НЦЗД РАМН, РГМУ, Москва
Russian Federation
Russian Federation
References
1. Мазуров В.И. Биохимия коллагеновых белков. М.: Медицина, 1974. 248.
2. Марков Х.М. Окись азота в физиологии и патологии почек// Вестник РАМН. 1996. 7: 73-78.
3. Марков Х.М. О биорегуляторной системе L-аргинин-окись азота. Патол. физиология и эксперим. Тер.1996; 1: 34-39.
4. Марков Х.М. Окись азота и окись углерода-новый класс сигнальных молекул. Успехи физиол. наук.1996; 4; т.27; 30-43.
5. Andreoli S. The dark side of nitric oxide: mediator of cell injury. Pediatr Nephrol.1995; 9: 779-82.
6. Anggard E. Nitric oxide: mediator, murderer and medicine./ Lancet. 1994; v.343; 1199-1206.
7. Bachmann S., Mundel P. Nitric oxide in the kidney: synthesis, localization and function. Am.J.Kidney Dis.1994; vol.24; 1: 112-29.
8. Baylis C., Bloch J. Nitric oxide in renal physiology and pathophysiology. Nephrol Dial Transplant 1996; 11; 1955-57.
9. Bredt D., Snyder S. Nitric oxide, a novel neuronal messenger. Neuron. 1992; v.8; 3-11.
10. Knowels P., Moncada S. Nitric oxide synthases in mammals. Biochem J.1994; 298; 819-20.
11. Moncada S., Higgs A. The L-arginine-nitric oxide pathway /New Engl J Med. 1993; vol.329; 2002-12.
12. Myers P. et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrocysteine than nitric oxide. Nature. 1990; vol.345; 161-63.
13. Noris M. et al. Increased nitric oxide formation in reccurent thrombotic microangiopathies: a possible mediator of microvascular injury. Am.J.Kidney Dis. 1996; vol.27; 6: 790-96.
14. Pfeilschifter J. et al. Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron. 1993; vol.64; 4: 518-25.
15. Radomsky M., Palmer R., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulation aggregation Proc.Natl.Acad.Sci USA. 1990; vol.87; 5193-97.
16. Star R.A. Southwestern Internal Medicine conference: Nitric Oxide. Am.J.Med.Sci. 1993; vol.306; 5: 348-57.
17. Wennmalm Ake et al. Metabolism and excretion of nitric oxide in humans. Circ Research. 1993; vol.73; 6: 1121-27.
Review
For citations:
Paunova S.S., Kycherenko A.G., Marcov Ch.M., Revenkova L.A., Goltsova N.L., Temerina E.A., Anokhina O.V., Komar V.I. The Pathogenetic Role Of Platelet Nitric Oxide In Children With Nephropathy. Nephrology and Dialysis. 2000;2(1-2):48-51. (In Russ.)
Views:
4
Email this article 